Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Price:
277 SEK
-1.91%
Market Closed
Updated:
May 18, 2024
Swedish Orphan Biovitrum AB (publ)
Cash from Operating Activities
|
Swedish Orphan Biovitrum AB (publ)
Cash from Operating Activities Peer Comparison
Comparables:
BIOG B
BONEX
VITR
PROB
BIOA B
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Cash from Operating Activities
kr4.7B
|
CAGR 3-Years
0%
|
CAGR 5-Years
17%
|
CAGR 10-Years
38%
|
|
|
Biogaia AB
STO:BIOG B
|
Cash from Operating Activities
kr426m
|
CAGR 3-Years
24%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
Bonesupport Holding AB
STO:BONEX
|
Cash from Operating Activities
kr7.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vitrolife AB
STO:VITR
|
Cash from Operating Activities
kr795m
|
CAGR 3-Years
18%
|
CAGR 5-Years
18%
|
CAGR 10-Years
22%
|
|
|
Probi AB
STO:PROB
|
Cash from Operating Activities
kr91.6m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
16%
|
|
|
BioArctic AB
STO:BIOA B
|
Cash from Operating Activities
kr309.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Swedish Orphan Biovitrum AB (publ)'s Cash from Operating Activities?
Cash from Operating Activities
4.7B
SEK
4.7B
SEK
Based on the financial report for Mar 31, 2024, Swedish Orphan Biovitrum AB (publ)'s Cash from Operating Activities amounts to 4.7B SEK.
What is Swedish Orphan Biovitrum AB (publ)'s Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
38%
38%
Over the last year, the Cash from Operating Activities growth was -3%.
You don't have any saved screeners yet
